Search

Your search keyword '"Taverne B"' showing total 96 results

Search Constraints

Start Over You searched for: Author "Taverne B" Remove constraint Author: "Taverne B"
96 results on '"Taverne B"'

Search Results

2. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

3. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

9. Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial

16. Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir

18. Promotion and Transnational Research in the South: Scientific and Political Lessons from Research on AIDS in Africa (Cameroon, Senegal)

19. Extraordinary long-term and fluctuating persistence of Ebola virus RNA in semen of survivors in Guinea: implications for public health

21. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

22. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

23. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

26. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

27. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

28. Extraordinary long-term and fluctuating persistence of Ebola virus RNA in semen of survivors in Guinea: implications for public health

31. (Re)vivre après Ebola : bilan à un an et perspectives d'une étude d'évaluation et accompagnement des patients déclarés guéris d'une infection par le virus Ebola en Guinée (cohorte PostEboGui).

33. Impact of Newly Available Drugs on Clinical Progression in Patients with Virological Failure after Exposure to Three Classes of Antiretrovirals

34. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

35. Grossesse sous efavirenz (Sustiva®) : à propos de 12 cas de patientes positives pour le VIH

36. Research ethics in health and social sciences : unpacking key issues and controversies from field study experience in South China, p. 153-159

37. Electronic Waste Dumped in the Global South: Ethical Issues in Practices and Research

38. Ethical Dilemmas Raised by HIV-Related Research in Laos. From Scientific Research to Production of a Radio Program

39. Implementing long-acting injectable antiretroviral treatments in Senegal: issues, challenges and conditions for introducing them. Qualitative study with healthcare providers and patients.

40. [Perceptions and use of Universal Health Coverage (Plan Sésame) among the elderly in Dakar (Senegal), impacts on health expenditure related to diabetes and hypertension].

41. Sexuality of adolescent girls born with HIV in Senegal: an anthropological analysis.

42. Treatment success or failure in children and adolescents born with HIV in rural Senegal: An anthropological perspective.

43. Understanding Long-term Evolution and Predictors of Sequelae of Ebola Virus Disease Survivors in Guinea: A 48-Month Prospective, Longitudinal Cohort Study (PostEboGui).

44. Does universal health coverage reduce out-of-pocket expenditures for medical consultations for people living with HIV in Senegal? An exploratory cross-sectional study.

45. Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal.

46. High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal.

47. [Second AIDS Scientific Day in Senegal (JSSS 2018) organized by the CNLS in Senegal, Diamniadio, Abdou Diouf International Conference Center, 3 to 5 December 2018].

48. The fourth HIV epidemic.

50. Characteristics of the musculoskeletal symptoms observed among survivors of Ebola virus disease in the Postebogui cohort in Guinea.

Catalog

Books, media, physical & digital resources